(Q35760415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

Christopher Griffiths

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alastair Forbes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Rosemary Greenwood

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

T N Brooklyn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M G S Dunnill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Shetty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J J Bowden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J D L Williams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C S Probert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

27 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

505-509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

Optimizing anti-TNF treatment in inflammatory bowel disease

7 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Clinical management of pyoderma gangrenosum.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Infliximab for the treatment of fistulas in patients with Crohn's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

EuroQol--a new facility for the measurement of health-related quality of life

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Treatment of pyoderma gangrenosum

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Pyoderma gangrenosum: a review of 86 patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Topical tacrolimus in the management of peristomal pyoderma gangrenosum

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Intralesional steroid therapy of pyoderma gangrenosum

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Topical treatment of pyoderma gangraenosum.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856164

Treatment of pyoderma gangrenosum with etanercept

25 September 2018

1 reference

12 December 2020

Pyoderma gangrenosum treated with cyclosporin A

1 reference

12 December 2020

Cyclosporine, azathioprine and local therapy for pyoderma gangrenosum

1 reference

12 December 2020

Treatment of pyoderma gangrenosum with methotrexate

1 reference

12 December 2020

Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease

1 reference

12 December 2020

Pyoderma gangrenosum: a report of 44 cases with follow-up

1 reference

12 December 2020

1 reference

12 December 2020

Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus

1 reference

12 December 2020

Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis

1 reference

12 December 2020

Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin

1 reference

12 December 2020

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience

1 reference

12 December 2020

Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease

1 reference

12 December 2020

Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum

1 reference

12 December 2020

Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab

1 reference

12 December 2020

Pyoderma gangrenosum: successful treatment with minocycline

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2005.074815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188920%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

PubMed publication ID

16188920

1 reference